Funding for this research was provided by:
Novartis Biociências SA (Novartis Biociências SA)
Received: 18 April 2022
Revised: 6 October 2022
Accepted: 12 October 2022
First Online: 28 October 2022
: The study had ethics committee approval of all participating research centers. All patients provided written informed consent to participate in the study. This study protocol was reviewed and approved by ethics committee CPCLIN - CENTRO DE PESQUISAS CLINICAS LTDA, approval number 3.725.041.
: Not applicable.
: Francisco Jose Forestiero, Ricardo T. Russo, Renato Calheiros, Roberto Tunala, and Gustavo Rosal are employed by Novartis Biociências. Marina Gabriela Birck, Guilherme Silva Julian, and Renato Watanabe de Oliveira are employed by IQVIA.